Drugs / EFV/FTC/TDF
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01565889 | Mar 2012 → Aug 2013 | HIV infectious disease, hepatitis C virus infection | Gilead Sciences | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EFV/FTC/TDF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01565889 ↗ |
| Route | Oral | “administered orally once daily” NCT01565889 ↗ |